CAS: 2313526-86-0
N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide
CAS:2313526-86-0
Formula:
C21H19F3N4O4
Purity:
99.92%
Molecular weight:
448.3952
Ref: IN-DA01KL03
| 5mg | 552.00 € | ||
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide
CAS:2313526-86-0
N-(2-(1H-1,2,4-Triazol-1-yl)-5-(trifluoromethoxy)phenyl)-4-(cyclopropylmethoxy)-3-methoxybenzamide is a modulator of metabotropic glutamate receptors. It has been shown to be orally …
Formula:
C21H19F3N4O4
Purity:
Min. 95%
Molecular weight:
448.4 g/mol
Ref: 3D-NSD52686
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
VU6012962
CAS:2313526-86-0
VU6012962 is an orally bioavailable negative allosteric modulator of CNS-penetrant metabotropic glutamate receptor 7(mGlu7; IC50: …
Formula:
C21H19F3N4O4
Purity:
97% - 98.31%
Color and Shape:
Solid
Molecular weight:
448.4
Ref: TM-T13323
| 1mg | 36.00 € | ||
| 2mg | 52.00 € | ||
| 5mg | 78.00 € | ||
| 10mg | 124.00 € | ||
| 25mg | 233.00 € | ||
| 50mg | 418.00 € | ||
| 100mg | 611.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Tuesday 11 Feb 2025
